Al-Dawaa Medical Services Company

SASE:4163 Stok Raporu

Piyasa değeri: ر.س7.6b

Al-Dawaa Medical Services Gelecekteki Büyüme

Future kriter kontrolleri 4/6

Al-Dawaa Medical Services kazanç ve gelirin sırasıyla yıllık 15.9% ve 5.6% oranında artacağı tahmin edilmektedir. EPS'nin yıllık 16.5% oranında büyümesi beklenmektedir. Özkaynak kârlılığının 3 yıl içinde 30.1% olacağı tahmin edilmektedir.

Anahtar bilgiler

15.9%

Kazanç büyüme oranı

16.5%

EPS büyüme oranı

Consumer Retailing kazanç büyümesi19.4%
Gelir büyüme oranı5.6%
Gelecekteki özkaynak getirisi30.1%
Analist kapsamı

Low

Son güncelleme08 Oct 2024

Gelecekteki son büyüme güncellemeleri

Recent updates

Benign Growth For Al-Dawaa Medical Services Company (TADAWUL:4163) Underpins Its Share Price

Sep 24
Benign Growth For Al-Dawaa Medical Services Company (TADAWUL:4163) Underpins Its Share Price

The Returns At Al-Dawaa Medical Services (TADAWUL:4163) Aren't Growing

Jul 29
The Returns At Al-Dawaa Medical Services (TADAWUL:4163) Aren't Growing

Market Still Lacking Some Conviction On Al-Dawaa Medical Services Company (TADAWUL:4163)

Jun 03
Market Still Lacking Some Conviction On Al-Dawaa Medical Services Company (TADAWUL:4163)

Al-Dawaa Medical Services' (TADAWUL:4163) Strong Earnings Are Of Good Quality

May 08
Al-Dawaa Medical Services' (TADAWUL:4163) Strong Earnings Are Of Good Quality

Al-Dawaa Medical Services (TADAWUL:4163) Hasn't Managed To Accelerate Its Returns

Apr 05
Al-Dawaa Medical Services (TADAWUL:4163) Hasn't Managed To Accelerate Its Returns

Al-Dawaa Medical Services (TADAWUL:4163) Has Some Way To Go To Become A Multi-Bagger

Dec 26
Al-Dawaa Medical Services (TADAWUL:4163) Has Some Way To Go To Become A Multi-Bagger

Al-Dawaa Medical Services (TADAWUL:4163) Has Announced A Dividend Of SAR1.25

Sep 03
Al-Dawaa Medical Services (TADAWUL:4163) Has Announced A Dividend Of SAR1.25

Return Trends At Al-Dawaa Medical Services (TADAWUL:4163) Aren't Appealing

Jul 13
Return Trends At Al-Dawaa Medical Services (TADAWUL:4163) Aren't Appealing

Is Al-Dawaa Medical Services Company (TADAWUL:4163) Expensive For A Reason? A Look At Its Intrinsic Value

Jun 22
Is Al-Dawaa Medical Services Company (TADAWUL:4163) Expensive For A Reason? A Look At Its Intrinsic Value

Returns On Capital Signal Tricky Times Ahead For Al-Dawaa Medical Services (TADAWUL:4163)

Apr 10
Returns On Capital Signal Tricky Times Ahead For Al-Dawaa Medical Services (TADAWUL:4163)

Some Shareholders Feeling Restless Over Al-Dawaa Medical Services Company's (TADAWUL:4163) P/E Ratio

Mar 14
Some Shareholders Feeling Restless Over Al-Dawaa Medical Services Company's (TADAWUL:4163) P/E Ratio

Is Al-Dawaa Medical Services Company (TADAWUL:4163) Trading At A 34% Discount?

Dec 08
Is Al-Dawaa Medical Services Company (TADAWUL:4163) Trading At A 34% Discount?

Kazanç ve Gelir Büyüme Tahminleri

SASE:4163 - Analistlerin gelecek tahminleri ve geçmiş finansal verileri (SAR Millions )
TarihGelirKazançlarSerbest Nakit AkışıFaaliyetlerden NakitAvg. Analist Sayısı
12/31/20267,0155195148374
12/31/20256,6004584367575
12/31/20246,1603785398815
9/30/20246,187359443666N/A
6/30/20246,000355474703N/A
3/31/20245,850348597836N/A
12/31/20235,741329502726N/A
9/30/20235,742326704848N/A
6/30/20235,612303716881N/A
3/31/20235,485295529743N/A
12/31/20225,372305528778N/A
9/30/20225,212285266651N/A
6/30/20225,163275142519N/A
3/31/20225,119247217561N/A
12/31/20215,034239361670N/A
9/30/20214,977254413649N/A
6/30/20214,958300400644N/A
3/31/20214,932286348566N/A
12/31/20204,962246166378N/A
12/31/20193,962233356515N/A
12/31/20183,797228244392N/A
12/31/20173,376121N/A568N/A

Analist Gelecek Büyüme Tahminleri

Kazançlar ve Tasarruf Oranları: 4163 'nin tahmini kazanç büyümesi (yıllık 15.9% ) tasarruf oranının ( 14.7% ) üzerindedir.

Kazançlar ve Piyasa: 4163 şirketinin kazançlarının (yıllık 15.9% ) SA pazarından (yıllık 7.8% ) daha hızlı büyümesi öngörülüyor.

Yüksek Büyüme Kazançları: 4163 şirketinin kazançlarının artması bekleniyor, ancak önemli ölçüde.

Gelir ve Pazar: 4163 şirketinin gelirinin (yıllık 5.6% ) SA pazarından (yıllık 1.3% ) daha hızlı büyümesi öngörülüyor.

Yüksek Büyüme Geliri: 4163 şirketinin gelirinin (yıllık 5.6% ) yıllık 20% oranından daha yavaş büyümesi öngörülüyor.


Hisse Başına Kazanç Büyüme Tahminleri


Gelecekteki Özkaynak Getirisi

Gelecekteki ROE: 4163 'in Özsermaye Getirisi'nin 3 yıl içinde yüksek olması tahmin ediliyor ( 30.1 %)


Büyüyen şirketleri keşfedin